Living with Neuroendocrine TumorsPeople with neuroendocrine tumors can lead meaningful, active, productive lives. Learn how you can make the most of every day. Managing NET symptoms Eating right Being active, staying safe Managing emotions Finding support See how others live with NETs made one or more lifestyle changes due to NETs2 0 % report general fatigue/muscle weakness2 0 % experienced diarrhea2 0 % The latest in NETRF News New ALT Biomarker Enhances Prognostic Accuracy in Pancreatic Neuroendocrine Tumors Pancreatic neuroendocrine tumors (PanNETs) can have a variety of behaviors. Some stay slow-growing for years, Belzutifan Approved for Pheo Para In a breakthrough for those with advanced pheochromocytoma and paraganglioma (Pheo/Para), the U.S. Food and Driving Progress in NET Research: An Interview with Dr. Anna Greene In a recent interview with CancerNetwork®, Dr. Anna Greene, Director of Research at the Neuroendocrine Browse our Youtube Channel Video Library Subscribe to NETRF Podcast Attend a NET patient conference Patient Events Find support groups in your area Check out patient advocacy groups 2Singh S, Granberg D, Wolin E, et al. Patient-reported burden of a neuroendocrine tumor (NET) diagnosis: results from the first global survey of patients with NETs. J Glob Oncol. 2016;2(1):43-53.
New ALT Biomarker Enhances Prognostic Accuracy in Pancreatic Neuroendocrine Tumors Pancreatic neuroendocrine tumors (PanNETs) can have a variety of behaviors. Some stay slow-growing for years,
Belzutifan Approved for Pheo Para In a breakthrough for those with advanced pheochromocytoma and paraganglioma (Pheo/Para), the U.S. Food and
Driving Progress in NET Research: An Interview with Dr. Anna Greene In a recent interview with CancerNetwork®, Dr. Anna Greene, Director of Research at the Neuroendocrine